Author:
Nagel-Wolfrum Kerstin,Möller Fabian,Penner Inessa,Baasov Timor,Wolfrum Uwe
Funder
BMBF
Deutsche Forschungsgemeinschaft (DE)
European Community
FAUN-Stiftung, Nuremberg
Foundation Fighting Blindness (FFB), U.S.A.
Tistou & Charlotte Kerstan Stiftung
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine,Biotechnology
Reference149 articles.
1. Peltz SW, Morsy M, Welch EM, Jacobson A. Ataluren as an agent for therapeutic nonsense suppression. Annu Rev Med. 2013;64:407–25.
2. Mort M, Ivanov D, Cooper DN, Chuzhanova NA. A meta-analysis of nonsense mutations causing human genetic disease. Hum Mutat. 2008;29:1037–47.
3. Moosajee M, Ramsden SC, Black GC, Seabra MC, Webster AR. Clinical utility gene card for: choroideremia. Eur J Hum Genet. 2014;22. doi: 10.1038/ejhg.2013.183 .
4. Overlack N, Goldmann T, Wolfrum U, Nagel-Wolfrum K. Current therapeutic strategies for human Usher syndrome. In: Ahuja S, editor. Usher syndrome: pathogenesis, diagnosis and therapy. New York: Nova Science Publishers, Inc.; 2011. p. 377–95.
5. Xiao-Jie L, Hui-Ying X, Zun-Ping K, Jin-Lian C, Li-Juan J. CRISPR-Cas9: a new and promising player in gene therapy. J Med Genet. 2015;52:289–96.
Cited by
86 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献